申请人:GENENTECH, INC.
公开号:US20180086720A1
公开(公告)日:2018-03-29
The present invention relates to compounds of formula (I):
and salts thereof, wherein: R
1
-R
4
have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of BRG1, BRM and/or PB1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various BRG1-mediated disorders, BRM-mediated disorders and/or PB1-mediated disorders.